With box warnings

Without box warnings

Branded

Generic

3 results

ambien
(zolpidem tartrate)
sanofi-aventis U.S. LLC
Usage: AMBIEN (zolpidem tartrate) is indicated for the short-term treatment of insomnia, specifically for difficulties with sleep initiation. It effectively reduces sleep latency for up to 35 days, as demonstrated in controlled clinical studies lasting 4–5 weeks.
ambien
(zolpidem tartrate)
sanofi-aventis U.S. LLC
Usage: AMBIEN CR (zolpidem tartrate extended-release tablets) is indicated for the short-term treatment of insomnia, particularly for difficulties with sleep onset and/or maintenance, as measured by wake time after sleep onset. Clinical trials supporting its efficacy lasted up to 24 weeks.
zolpidem tartrate
(Zolpidem Tartrate)
Lupin Pharmaceuticals, Inc.
Usage: Zolpidem tartrate extended-release tablets are indicated for the short-term treatment of insomnia, specifically for difficulties with sleep onset and/or maintenance, as measured by wake time after sleep onset.

gamma-Aminobutyric Acid A Receptor Positive Modulator class drugs

ambien